ATE334191T1 - Transplantate für myokardiale narben, sowie methode und zelluläre präparationen dafür - Google Patents

Transplantate für myokardiale narben, sowie methode und zelluläre präparationen dafür

Info

Publication number
ATE334191T1
ATE334191T1 AT98923950T AT98923950T ATE334191T1 AT E334191 T1 ATE334191 T1 AT E334191T1 AT 98923950 T AT98923950 T AT 98923950T AT 98923950 T AT98923950 T AT 98923950T AT E334191 T1 ATE334191 T1 AT E334191T1
Authority
AT
Austria
Prior art keywords
transplants
cellular preparations
myocardial scars
grafts
cardiomyocytes
Prior art date
Application number
AT98923950T
Other languages
English (en)
Inventor
Donald A G Mickle
Ren-Ke Li
Richard D Weisel
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE334191T1 publication Critical patent/ATE334191T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AT98923950T 1997-05-28 1998-05-28 Transplantate für myokardiale narben, sowie methode und zelluläre präparationen dafür ATE334191T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/863,882 US6110459A (en) 1997-05-28 1997-05-28 Transplants for myocardial scars and methods and cellular preparations

Publications (1)

Publication Number Publication Date
ATE334191T1 true ATE334191T1 (de) 2006-08-15

Family

ID=25342008

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06002350T ATE488244T1 (de) 1997-05-28 1998-05-28 Transplantate für myokardiale narben, methoden and zelluläre präparationen dafür
AT98923950T ATE334191T1 (de) 1997-05-28 1998-05-28 Transplantate für myokardiale narben, sowie methode und zelluläre präparationen dafür

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06002350T ATE488244T1 (de) 1997-05-28 1998-05-28 Transplantate für myokardiale narben, methoden and zelluläre präparationen dafür

Country Status (8)

Country Link
US (2) US6110459A (de)
EP (2) EP0985028B1 (de)
JP (1) JP2002501513A (de)
AT (2) ATE488244T1 (de)
AU (1) AU753388B2 (de)
CA (1) CA2291138C (de)
DE (2) DE69835354T2 (de)
WO (1) WO1998054301A2 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040087498A1 (en) * 1991-02-28 2004-05-06 Novo Nordisk Health Care Ag Modified factor VII
US6443974B1 (en) * 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
US6110459A (en) * 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
US6099832A (en) * 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
US6775574B1 (en) * 1997-11-07 2004-08-10 Medtronic, Inc. Method and system for myocardial infarction repair
US7115417B1 (en) 1998-05-01 2006-10-03 Chancellor Michael B Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
US6866842B1 (en) 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
ATE382681T1 (de) * 1998-07-31 2008-01-15 Genzyme Corp Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
EP1374889A1 (de) * 1999-06-25 2004-01-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Verfahren zur Induktion von Angiogenese mittels Mikro-Organen
EP1200559A2 (de) * 1999-07-23 2002-05-02 Diacrin, Inc. Muskelzellen und ihre verwendung in der herzwiederherstellung
US20030113301A1 (en) * 1999-07-23 2003-06-19 Albert Edge Muscle cells and their use in cardiac repair
DE10003521A1 (de) * 2000-01-27 2001-08-09 Medigene Ag Vorrichtung zum Herstellen eines dreidimensionalen Matrixkörpers, Multi-Well-Platte, Lösung zum Kultivieren von Säugerkardiomyocyten, Verfahren zum Kultivieren einer Zellkultur, Vorrichtung für die Messung isometrischer Kraftparameter von Zellkulturen sowie Verfahren zum meßbaren Verfolgen von Kontraktionen eines in eine Trägersubstanz eingelagerten Zellgewebes
ATE365045T1 (de) 2000-04-14 2007-07-15 Univ Pittsburgh Vermehrung des weich- sowie des knochengewebes anhand von aus muskeln stammenden vorläuferzellen,sowie damit verbundene zusammensetzungen und behandlungsformen
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
US20110091428A1 (en) * 2000-07-31 2011-04-21 New York Medical College Compositions of adult organ stem cells and uses thereof
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20020061587A1 (en) * 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
US7862810B2 (en) * 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7491385B2 (en) * 2001-09-05 2009-02-17 Genegrafts Ltd. Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
US7294333B1 (en) 2000-10-20 2007-11-13 Genegrafts Ltd. Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
US6659995B1 (en) * 2000-11-17 2003-12-09 Syde A. Taheri Autologous myocyte micro granual retrieval and implantation (AMMGRI)
DE10106512C1 (de) * 2001-02-13 2002-05-23 Axel Haverich Verfahren zur Herstellung eines biologischen Gewebes unter Verwendung einer Kollagenunterlage und zugehöriges Gewebekonstrukt
EP1372398B1 (de) 2001-02-23 2013-07-10 The University of Pittsburgh Rasche herstellung von stammzellemmatrices für die gewebe- und organbehandlung und -reparatur
US7341062B2 (en) * 2001-03-12 2008-03-11 Bioheart, Inc. Method of providing a dynamic cellular cardiac support
CN1533431A (zh) * 2001-04-13 2004-09-29 细胞移植的方法和试剂
KR100694442B1 (ko) * 2001-04-13 2007-03-12 (주)안트로젠 인캡슐화된 세포 인디케이터 시스템
US7993365B2 (en) 2001-06-08 2011-08-09 Morris Innovative, Inc. Method and apparatus for sealing access
CA2448900C (en) * 2001-06-08 2011-05-17 Morris Innovative Research, Inc. Method and apparatus for sealing access
US20070038244A1 (en) * 2001-06-08 2007-02-15 Morris Edward J Method and apparatus for sealing access
GB2393734B (en) * 2001-07-12 2005-07-27 Geron Corp Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
US7732199B2 (en) 2001-07-12 2010-06-08 Geron Corporation Process for making transplantable cardiomyocytes from human embryonic stem cells
WO2003093433A2 (en) * 2002-05-02 2003-11-13 Regents Of The University Of Minnesota Fibrin-based biomatrix
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
WO2004009767A2 (en) * 2002-07-23 2004-01-29 Boston Scientific Limited Cell therapy for regeneration
JP2005534430A (ja) * 2002-08-06 2005-11-17 ジェンベック， インコーポレイテッド 改良された注射システム
US7618948B2 (en) 2002-11-26 2009-11-17 Medtronic, Inc. Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
US7605249B2 (en) 2002-11-26 2009-10-20 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of siRNA
US7829694B2 (en) 2002-11-26 2010-11-09 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of siRNA
US7627373B2 (en) 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US7994149B2 (en) 2003-02-03 2011-08-09 Medtronic, Inc. Method for treatment of Huntington's disease through intracranial delivery of sirna
US7732591B2 (en) * 2003-11-25 2010-06-08 Medtronic, Inc. Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
ES2354304T3 (es) 2003-04-25 2011-03-11 The University Of Pittsburgh Células derivadas del músculo (mdcs) para promover y potenciar la regeneración y reparación de nervios.
WO2005072764A2 (en) * 2004-01-16 2005-08-11 Novocell, Inc. Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
US7840263B2 (en) 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US20050208090A1 (en) * 2004-03-18 2005-09-22 Medtronic, Inc. Methods and systems for treatment of neurological diseases of the central nervous system
US7452718B2 (en) * 2004-03-26 2008-11-18 Geron Corporation Direct differentiation method for making cardiomyocytes from human embryonic stem cells
US20050214938A1 (en) * 2004-03-26 2005-09-29 Gold Joseph D Cardiac bodies: clusters of spontaneously contracting cells for regenerating cardiac function
US7764995B2 (en) * 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US8874204B2 (en) * 2004-12-20 2014-10-28 Cardiac Pacemakers, Inc. Implantable medical devices comprising isolated extracellular matrix
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US20060134071A1 (en) * 2004-12-20 2006-06-22 Jeffrey Ross Use of extracellular matrix and electrical therapy
US20060263338A1 (en) * 2005-03-04 2006-11-23 Jacoby Douglas B Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
WO2006103770A1 (ja) * 2005-03-30 2006-10-05 Osaka Prefectural Hospital Organization 血管新生制御方法
US20070059288A1 (en) * 2005-03-31 2007-03-15 Dinsmore Jonathan H Treatment for heart disease
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US8303972B2 (en) 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US20060253068A1 (en) * 2005-04-20 2006-11-09 Van Bilsen Paul Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
US7902352B2 (en) * 2005-05-06 2011-03-08 Medtronic, Inc. Isolated nucleic acid duplex for reducing huntington gene expression
WO2006121960A2 (en) * 2005-05-06 2006-11-16 Medtronic, Inc. Methods and sequences to suppress primate huntington gene expression
EP1885185A4 (de) * 2005-05-09 2010-04-07 Mytogen Inc Zellkardiomyoplastie als begleittherapie bei herzpatienten
EP1910518B1 (de) 2005-06-22 2019-05-08 Asterias Biotherapeutics, Inc. Differenzierung pluripotenter primatenstammzellen zu zellen der kardiomyozytenlinie
US9133517B2 (en) * 2005-06-28 2015-09-15 Medtronics, Inc. Methods and sequences to preferentially suppress expression of mutated huntingtin
US20080280843A1 (en) * 2006-05-24 2008-11-13 Van Bilsen Paul Methods and kits for linking polymorphic sequences to expanded repeat mutations
US8038595B2 (en) * 2006-01-25 2011-10-18 Beth Israel Deaconess Medical Center Devices and methods for tissue transplant and regeneration
MX2008010137A (es) * 2006-02-07 2009-01-07 Organogenesis Inc Construcciones de tejido diseñadas por bioingenieria y sus usos cardiacos.
US9273356B2 (en) 2006-05-24 2016-03-01 Medtronic, Inc. Methods and kits for linking polymorphic sequences to expanded repeat mutations
US20080039415A1 (en) * 2006-08-11 2008-02-14 Gregory Robert Stewart Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
WO2008027984A1 (en) 2006-08-29 2008-03-06 Isolagen Technologies, Inc. Methods for culturing minimally-passaged fibroblasts and uses thereof
CN101610793B (zh) 2006-09-14 2012-10-24 迈德詹尼克斯医疗以色列有限公司 长效药物制剂
US20080112927A1 (en) * 2006-10-23 2008-05-15 Genegrafts Ltd. Cells and methods utilizing same for modifying the electrophysiological function of excitable tissues
US9375440B2 (en) * 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US8324367B2 (en) 2006-11-03 2012-12-04 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US7988668B2 (en) * 2006-11-21 2011-08-02 Medtronic, Inc. Microsyringe for pre-packaged delivery of pharmaceuticals
US7819842B2 (en) * 2006-11-21 2010-10-26 Medtronic, Inc. Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites
US7754486B2 (en) * 2006-12-26 2010-07-13 Institut De Recherche En Hematologie Et Transplantation Culture medium named MV06 for both endothelial and myocardiac cells
US20100303770A1 (en) * 2006-12-28 2010-12-02 John Maslowski Methods for culturing dermal cells for treatment of skin injuries such as burns
WO2008086040A1 (en) 2007-01-11 2008-07-17 University Of Pittsburgh Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same
US20080171906A1 (en) * 2007-01-16 2008-07-17 Everaerts Frank J L Tissue performance via hydrolysis and cross-linking
US9283302B2 (en) * 2011-12-16 2016-03-15 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
US9066993B2 (en) * 2007-05-10 2015-06-30 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
US20090024106A1 (en) * 2007-07-17 2009-01-22 Morris Edward J Method and apparatus for maintaining access
EP2219656A2 (de) 2007-11-09 2010-08-25 New York Medical College Verfahren zur reparatur und/oder regeneration von geschädigtem myokard mit varianten des hepatozyten-wachstumsfaktors
KR101809863B1 (ko) 2008-01-30 2017-12-15 아스테리아스 바이오세라퓨틱스, 인크. 줄기 세포 유래 심근세포 배양용 합성 표면
WO2009155236A1 (en) 2008-06-16 2009-12-23 Morris Innovative Research, Inc. Method and apparatus for sealing access
EP2328596B1 (de) 2008-08-18 2019-03-06 University of Pittsburgh - Of the Commonwealth System of Higher Education Knochenaufbau anhand von vorläuferzusammensetzungen aus muskeln in biokompatibler matrix und behandlungen
US8529883B2 (en) 2010-05-07 2013-09-10 Fibrocell Technologies, Inc. Dosage unit formulations of autologous dermal fibroblasts
TW201219573A (en) 2010-09-22 2012-05-16 Ct Hospitalier Universitaire Vaudois Anti-fibrotic response provided by fetal cells to implants and delivery systems
WO2012051505A1 (en) 2010-10-14 2012-04-19 Fibrocell Science, Inc. Treatment of vocal cords with autologous dermal fibroblast formulation
WO2012111000A1 (en) * 2011-02-14 2012-08-23 Technion Research And Development Foundation Ltd Tissue engineering construct comprising fibrin
CN104105493A (zh) 2011-12-08 2014-10-15 耶达研究及发展有限公司 哺乳动物胎儿肺细胞以及其治疗用途
AU2014277754B2 (en) * 2012-09-24 2017-04-13 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
EP3310388B1 (de) 2015-06-18 2021-10-06 Yeda Research and Development Co., Ltd. Konditionierungsprotokolle und verwendung davon zur geweberegeneration
GB2546978B (en) * 2016-02-01 2019-01-23 Siemens Healthcare Gmbh Methods for visualising heart scar tissue
EP3778902A4 (de) * 2018-03-30 2021-12-29 Kyoto University Zellproduktionsverfahren
CN110358723A (zh) * 2019-05-08 2019-10-22 广州医科大学附属第二医院 一种成年小鼠心脏成纤维细胞的培养方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US5197985A (en) * 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5543318A (en) * 1991-06-12 1996-08-06 Smith; David A. Method of isolation, culture and proliferation of human atrial myocytes
CA2111347A1 (en) * 1991-06-12 1992-12-23 David A. Smith Method for inducing human myocardial cell proliferation
AU4385393A (en) * 1992-05-29 1993-12-30 General Hospital Corporation, The Arterial introduction of myoblasts
AU1052795A (en) * 1993-11-08 1995-05-29 University Of Southern California Compositions and methods for transduction of cells
US5602301A (en) * 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
US5785966A (en) * 1994-06-15 1998-07-28 Coles; John G. Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
US5919449A (en) * 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
US6099832A (en) * 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
US6110459A (en) * 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
EP1200559A2 (de) * 1999-07-23 2002-05-02 Diacrin, Inc. Muskelzellen und ihre verwendung in der herzwiederherstellung

Also Published As

Publication number Publication date
CA2291138C (en) 2010-10-26
US20080159997A1 (en) 2008-07-03
EP1690546A2 (de) 2006-08-16
DE69835354T2 (de) 2007-08-02
EP0985028B1 (de) 2006-07-26
DE69835354D1 (de) 2006-09-07
AU753388B2 (en) 2002-10-17
AU7633198A (en) 1998-12-30
WO1998054301A3 (en) 1999-04-01
JP2002501513A (ja) 2002-01-15
US6110459A (en) 2000-08-29
ATE488244T1 (de) 2010-12-15
EP0985028A2 (de) 2000-03-15
CA2291138A1 (en) 1998-12-03
WO1998054301B1 (en) 1999-05-06
DE69842009D1 (de) 2010-12-30
EP1690546A3 (de) 2006-10-11
WO1998054301A2 (en) 1998-12-03
EP1690546B1 (de) 2010-11-17

Similar Documents

Publication Publication Date Title
ATE334191T1 (de) Transplantate für myokardiale narben, sowie methode und zelluläre präparationen dafür
ATE424454T1 (de) Transplantate für myokardiale narben
CA2238011A1 (en) A biologic material comprising an efficient culture of bone marrow stem cells partially or completely differentiated into connective tissue cells and a three-dimensional biocompatible and biodegradable matrix consisting of a hyaluronic acid derivative
EP1100870A4 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
WO1999062425A3 (en) Bioengineered vascular graft prostheses
WO2003039489A3 (en) Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
ES2160116T3 (es) Modelo de equivalente de cornea producido in vitro.
GB8803697D0 (en) Clinical developments using amniotic membrane cells
PL337019A1 (en) Peptide-coated implants and method of obtaining them
AU8476698A (en) Human mesenchymal stem cells from peripheral blood
ATE265191T1 (de) Herstellungsverfahren von gewebe zur implantation
AU1615599A (en) Differentiation of adipose stromal cells into osteoblasts and uses thereof
WO1994007432A3 (en) Porous vascular implants
ATE295875T1 (de) Verfahren zur in vitro herstellung von knochen
EP1082057A4 (de) Biologisch modellierte implantierbare prothesen
ATE148502T1 (de) Verfahren, zubereitungen und anordnungen für zellzucht
ATE263588T1 (de) Verfahren zur herstellung eines bioartifiziellen transplantates
WO2000034442A3 (en) Application of shear flow stress to smooth muscle cells for the production of implantable structures
NO992569D0 (no) FremgangsmÕter for Õ hindre podingsforkastelse i transplantasjon og for fremstilling av en universell genterapi vertcelle ved Õ anvende lymfocytt aktivering (LAG-3)
AU1154701A (en) Hair transplantation
AU7335796A (en) Novel peptide
GB9825096D0 (en) Cells,culture methods and their uses
AU3685697A (en) Method of treating leather with improved retanning agents
EP1702979A3 (de) Verbesserte keratinozytenkultur und deren verwendungen
AU3000601A (en) Method for production of a skin graft and the graft produced thereby

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties